SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-035879
Filing Date
2024-08-08
Accepted
2024-08-08 07:52:02
Documents
98
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q akba-20240630.htm   iXBRL 10-Q 2045281
2 EX-10.1 exhibit101seventhamendment.htm EX-10.1 39025
3 EX-10.2 exhibit102akebiaamendment2.htm EX-10.2 28542
4 EX-10.3 exhibit103akebiaviforamend.htm EX-10.3 42165
5 EX-10.4 exhibit104akebiavifortermi.htm EX-10.4 116936
6 EX-10.5 exhibit105akebiakreosfirst.htm EX-10.5 31612
7 EX-31.1 exhibit311-q220241.htm EX-31.1 10974
8 EX-31.2 exhibit312-q220241.htm EX-31.2 11034
9 EX-32.1 exhibit321-q220241.htm EX-32.1 7532
15 akba-20240630_g1.gif GRAPHIC 3995
  Complete submission text file 0001628280-24-035879.txt   9797066

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT akba-20240630.xsd EX-101.SCH 81937
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT akba-20240630_cal.xml EX-101.CAL 85396
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT akba-20240630_def.xml EX-101.DEF 353899
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT akba-20240630_lab.xml EX-101.LAB 847183
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT akba-20240630_pre.xml EX-101.PRE 594364
101 EXTRACTED XBRL INSTANCE DOCUMENT akba-20240630_htm.xml XML 1151328
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36352 | Film No.: 241186116
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)